Phreesia Target Price

Analysts' average 12-month price target for Phreesia is $11.

Get informed when a big investor buys or sells

+ Follow

Share Price

$10.1

Average Target Price

$11.33

12.2% upside

3 analysts in the last 4 months

High: $13 | Low: $10

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-09-04	D.A. Davidson	$13	28.7% upside
2026-09-04	Robert W. BairdJoe Vruwink	$11	8.9% upside
2026-09-03	Wells FargoStan Berenshteyn	$10	1% downside
2026-05-28	Piper SandlerJessica Tassan	$12	18.8% upside
2026-05-28	D.A. DavidsonClark Wright	$14	38.6% upside
2026-05-28	Truist FinancialJailendra Singh	$12	18.8% upside
2026-05-28	Canaccord Genuity	$16	58.4% upside
2026-05-20	Wells FargoStan Berenshteyn	$9	10.9% downside
2026-05-14	Barclays	$10	1% downside
2026-02-04	Mizuho SecuritiesSteven Valiquette	$22	117.8% upside
2026-01-23	D.A. Davidson	$30	197% upside
2026-01-08	Wells FargoStan Berenshteyn	$30	197% upside
2026-01-08	Truist Financial	$24	137.6% upside
2025-12-16	Barclays	$24	137.6% upside
2025-12-10	Truist Financial	$29	187.1% upside
2025-12-10	Mizuho SecuritiesSteven Valiquette	$28	177.2% upside
2025-12-10	Robert W. Baird	$25	147.5% upside
2025-12-09	Canaccord GenuityRichard Close	$33	226.7% upside
2025-12-08	Barclays	$26	157.4% upside
2025-12-02	D.A. DavidsonClark Wright	$35	246.5% upside
2025-10-08	KeyBanc	$32	216.8% upside
2025-09-08	JMP SecuritiesAaron Kimson	$34	236.6% upside
2025-09-05	Truist Financial	$36	256.4% upside
2025-09-05	Raymond James	$33	226.7% upside
2025-09-05	D.A. Davidson	$33	226.7% upside
2025-09-05	Canaccord GenuityRichard Close	$38	276.2% upside
2024-12-11	Robert W. BairdJoe Vruwink	$30	197% upside
2024-11-29	D.A. DavidsonGil Luria	$32	216.8% upside
2024-09-06	Truist FinancialJailendra Singh	$31	206.9% upside
2024-09-06	Robert W. BairdJoe Vruwink	$34	236.6% upside
2024-09-05	Piper SandlerSean Wieland	$30	197% upside
2024-05-31	Canaccord GenuityRichard Close	$34	236.6% upside
2024-05-29	Truist FinancialJailendra Singh	$35	246.5% upside
2024-05-24	KeyBancScott Schoenhaus	$30	197% upside
2024-03-21	JMP SecuritiesAaron Kimson	$30	197% upside
2024-03-18	Robert W. BairdJoe Vruwink	$31	206.9% upside
2024-03-15	RBC CapitalSean Dodge	$23	127.7% upside
2023-12-06	NeedhamRyan MacDonald	$29	187.1% upside
2023-09-07	StephensJeff Garro	$37	266.3% upside
2023-01-04	NeedhamRyan MacDonald	$40	296% upside
2022-12-09	RBC Capital	$26	157.4% upside
2022-10-12	D.A. DavidsonRobert Simmons	$25	147.5% upside
2022-03-30	Robert W. BairdJoseph Vruwink	$51	405% upside
2022-03-30	Leerink PartnersStephanie Davis	$29	187.1% upside
2021-09-02	Cantor FitzgeraldSteven Halper	$70	593.1% upside
2021-07-12	KeyBancDonald Hooker	$73	622.8% upside
2021-06-08	Berenberg BankGal Munda	$70	593.1% upside

Phreesia (PHR) FAQ

Phreesia posts a target price of $11. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $11 for PHR means covering analysts, on average, see the stock 12.2% upside of $10.1 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for PHR's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Phreesia's other metric pages and overview cover the third.

Judging Phreesia against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in target price easier to interpret. Start with $11 here, then scan peer and history charts to see if the gap is persistent.